| Literature DB >> 32891740 |
Maria Teresa Oliveira1, Marco Campos2, Luís Lamego2, Diogo Magalhães2, Rui Menezes2, Renato Oliveira2, Francisco Patanita2, David A Ferreira3.
Abstract
Mast cell tumor (MCT) or mastocytoma is one of the most frequent malignant cutaneous tumors in the dog, and the second most frequent in the cat. Several mast cell tumor therapeutic approaches have been proposed in the past years for dogs and cats, resulting in very distinct outcomes. The current comprehensive literature review presents a critical approach to the scientific information published about the MCTs treatments and the subsequent prognosis and survival times, in dogs and in cats diagnosed with MCTs. A systematic review of the literature following the Cochrane principles and methodology was performed. The authors resorted to MEDLINE, Scopus, Google Scholar and Web of Science databases to select the 133 publications with evidence-based treatments for MCTs in companion animals. Results of the review suggest that the recommended treatment, prognosis and survival times for dogs and cats with MCTs depends at all times on the clinical staging, histological grade and location of the tumor.Entities:
Keywords: canine; feline; mast cell tumors; outcomes; prognosis factors; treatment
Mesh:
Year: 2020 PMID: 32891740 DOI: 10.1016/j.tcam.2020.100472
Source DB: PubMed Journal: Top Companion Anim Med ISSN: 1946-9837